Logo image of FAMI

FARMMI INC (FAMI) Stock Fundamental Analysis

NASDAQ:FAMI - Nasdaq - KYG332771495 - Common Stock - Currency: USD

1.82  +0.05 (+2.82%)

After market: 1.6602 -0.16 (-8.78%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to FAMI. FAMI was compared to 90 industry peers in the Food Products industry. FAMI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. FAMI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

FAMI had negative earnings in the past year.
In the past year FAMI has reported a negative cash flow from operations.
FAMI had positive earnings in 4 of the past 5 years.
FAMI had negative operating cash flow in 4 of the past 5 years.
FAMI Yearly Net Income VS EBIT VS OCF VS FCFFAMI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M

1.2 Ratios

The Return On Assets of FAMI (-2.49%) is worse than 66.67% of its industry peers.
FAMI's Return On Equity of -2.74% is on the low side compared to the rest of the industry. FAMI is outperformed by 62.22% of its industry peers.
FAMI has a worse Return On Invested Capital (0.39%) than 64.44% of its industry peers.
FAMI had an Average Return On Invested Capital over the past 3 years of 0.66%. This is significantly below the industry average of 8.67%.
Industry RankSector Rank
ROA -2.49%
ROE -2.74%
ROIC 0.39%
ROA(3y)0.11%
ROA(5y)0.78%
ROE(3y)0.09%
ROE(5y)0.93%
ROIC(3y)0.66%
ROIC(5y)1.86%
FAMI Yearly ROA, ROE, ROICFAMI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

Looking at the Operating Margin, with a value of 1.24%, FAMI is doing worse than 62.22% of the companies in the same industry.
In the last couple of years the Operating Margin of FAMI has declined.
Looking at the Gross Margin, with a value of 6.04%, FAMI is doing worse than 83.33% of the companies in the same industry.
FAMI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.24%
PM (TTM) N/A
GM 6.04%
OM growth 3Y-44.49%
OM growth 5Y-34.82%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.56%
GM growth 5Y-19.38%
FAMI Yearly Profit, Operating, Gross MarginsFAMI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

5

2. Health

2.1 Basic Checks

FAMI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for FAMI has been increased compared to 1 year ago.
Compared to 5 years ago, FAMI has more shares outstanding
Compared to 1 year ago, FAMI has an improved debt to assets ratio.
FAMI Yearly Shares OutstandingFAMI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K
FAMI Yearly Total Debt VS Total AssetsFAMI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

FAMI has an Altman-Z score of 1.52. This is a bad value and indicates that FAMI is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of FAMI (1.52) is worse than 62.22% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that FAMI is not too dependend on debt financing.
FAMI has a Debt to Equity ratio of 0.04. This is in the better half of the industry: FAMI outperforms 76.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 1.52
ROIC/WACC0.12
WACC3.36%
FAMI Yearly LT Debt VS Equity VS FCFFAMI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 16.10 indicates that FAMI has no problem at all paying its short term obligations.
FAMI has a Current ratio of 16.10. This is amongst the best in the industry. FAMI outperforms 100.00% of its industry peers.
FAMI has a Quick Ratio of 15.55. This indicates that FAMI is financially healthy and has no problem in meeting its short term obligations.
FAMI has a Quick ratio of 15.55. This is amongst the best in the industry. FAMI outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 16.1
Quick Ratio 15.55
FAMI Yearly Current Assets VS Current LiabilitesFAMI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1

3. Growth

3.1 Past

FAMI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -251.68%.
FAMI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -41.89%.
The Revenue has been growing by 17.50% on average over the past years. This is quite good.
EPS 1Y (TTM)-251.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-949.2%
Revenue 1Y (TTM)-41.89%
Revenue growth 3Y17.74%
Revenue growth 5Y17.5%
Sales Q2Q%-44.42%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FAMI Yearly Revenue VS EstimatesFAMI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1

4. Valuation

4.1 Price/Earnings Ratio

FAMI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FAMI Price Earnings VS Forward Price EarningsFAMI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, FAMI is valued cheaper than 87.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.09
FAMI Per share dataFAMI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for FAMI!.
Industry RankSector Rank
Dividend Yield N/A

FARMMI INC

NASDAQ:FAMI (5/20/2025, 8:00:02 PM)

After market: 1.6602 -0.16 (-8.78%)

1.82

+0.05 (+2.82%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-22 2022-08-22/bmo
Earnings (Next)N/A N/A
Inst Owners2.53%
Inst Owner Change0%
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap2.27M
Analysts0
Price TargetN/A
Short Float %4.73%
Short Ratio0.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B 0.01
P/tB 0.01
EV/EBITDA 5.09
EPS(TTM)-7.48
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-13.44
FCFYN/A
OCF(TTM)-13.42
OCFYN/A
SpS51.31
BVpS135.99
TBVpS135.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.49%
ROE -2.74%
ROCE 0.45%
ROIC 0.39%
ROICexc 0.39%
ROICexgc 0.39%
OM 1.24%
PM (TTM) N/A
GM 6.04%
FCFM N/A
ROA(3y)0.11%
ROA(5y)0.78%
ROE(3y)0.09%
ROE(5y)0.93%
ROIC(3y)0.66%
ROIC(5y)1.86%
ROICexc(3y)0.75%
ROICexc(5y)2.1%
ROICexgc(3y)0.75%
ROICexgc(5y)2.11%
ROCE(3y)0.77%
ROCE(5y)2.34%
ROICexcg growth 3Y-45.62%
ROICexcg growth 5Y-47.84%
ROICexc growth 3Y-45.62%
ROICexc growth 5Y-47.84%
OM growth 3Y-44.49%
OM growth 5Y-34.82%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.56%
GM growth 5Y-19.38%
F-Score2
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA 9.21
Cap/Depr 265.77%
Cap/Sales 0.05%
Interest Coverage 12.13
Cash Conversion N/A
Profit Quality N/A
Current Ratio 16.1
Quick Ratio 15.55
Altman-Z 1.52
F-Score2
WACC3.36%
ROIC/WACC0.12
Cap/Depr(3y)88.96%
Cap/Depr(5y)118.73%
Cap/Sales(3y)0.02%
Cap/Sales(5y)0.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-251.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-949.2%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-41.89%
Revenue growth 3Y17.74%
Revenue growth 5Y17.5%
Sales Q2Q%-44.42%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-61.17%
EBIT growth 3Y-34.64%
EBIT growth 5Y-23.41%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y77.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y77.86%
OCF growth 3YN/A
OCF growth 5YN/A